TGF-β1–a truly transforming growth factor in fibrosis and immunity

M Lodyga, B Hinz - Seminars in cell & developmental biology, 2020 - Elsevier
Abstract 'Jack of all trades, master of everything'is a fair label for transforming growth factor
β1 (TGF-β)–a cytokine that controls our life at many levels. In the adult organism, TGF-β1 is …

Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies

HR Hofer, RS Tuan - Stem cell research & therapy, 2016 - Springer
Adult mesenchymal stem cells (MSCs) represent a subject of intense experimental and
biomedical interest. Recently, trophic activities of MSCs have become the topic of a number …

[HTML][HTML] Targeting immunosuppression by TGF-β1 for cancer immunotherapy

G de Streel, S Lucas - Biochemical Pharmacology, 2021 - Elsevier
The TGF-β1 cytokine is a key mediator of many biological processes. Complex regulatory
mechanisms are in place that allow one single molecule to exert so many distinct …

TGF-β and mesenchymal stromal cells in regenerative medicine, autoimmunity and cancer

V de Araújo Farias, AB Carrillo-Gálvez, F Martin… - Cytokine & Growth …, 2018 - Elsevier
Multipotent mesenchymal stromal cells (MSCs) represent a promising cell-based therapy in
regenerative medicine and for the treatment of inflammatory/autoimmune diseases …

Mesenchymal stem cells for regenerative medicine in central nervous system

M Li, H Chen, M Zhu - Frontiers in Neuroscience, 2022 - frontiersin.org
Mesenchymal stem cells (MSCs) are multipotent stem cells, whose paracrine and
immunomodulatory potential has made them a promising candidate for central nervous …

Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer

A Metelli, M Salem, CH Wallace, BX Wu, A Li… - Journal of Hematology & …, 2018 - Springer
GARP (glycoprotein-A repetitions predominant) is a type I transmembrane cell surface
docking receptor for latent transforming growth factor-β (TGF-β) that is abundantly expressed …

Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8

J Stockis, S Liénart, D Colau… - Proceedings of the …, 2017 - National Acad Sciences
Human regulatory T cells (Tregs) suppress other T cells by converting the latent, inactive
form of TGF-β1 into active TGF-β1. In Tregs, TGF-β1 activation requires GARP, a …

Mechano growth factor (MGF) and transforming growth factor (TGF)-β3 functionalized silk scaffolds enhance articular hyaline cartilage regeneration in rabbit model

Z Luo, L Jiang, Y Xu, H Li, W Xu, S Wu, Y Wang, Z Tang… - Biomaterials, 2015 - Elsevier
Damaged cartilage has poor self-healing ability and usually progresses to scar or
fibrocartilaginous tissue, and finally degenerates to osteoarthritis (OA). Here we …

Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke

L Zhou, H Zhu, X Bai, J Huang, Y Chen, J Wen… - Stem cell research & …, 2022 - Springer
Ischemic stroke is one of the major causes of death and disability in the world. Currently,
most patients cannot choose intravenous thrombolysis or intravascular mechanical …

Therapeutic mesenchymal stromal cells for immunotherapy and for gene and drug delivery

G Almeida-Porada, AJ Atala, CD Porada - Molecular Therapy-Methods & …, 2020 - cell.com
Mesenchymal stromal cells (MSCs) possess several fairly unique properties that, when
combined, make them ideally suited for cellular-based immunotherapy and as vehicles for …